CXCL12 modulators (Rappaport)

N/A

Report date: 2025/03/18 20:00:05

Base Information

Drug NameCXCL12 modulators (Rappaport)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionC-X-C motif chemokine ligand 12 modulators
TargetsC-X-C motif chemokine ligand 12
Therapy Area/IndicationsMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIsrael
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesRappaport Family Institute for Research in the Medical Sciences
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBioRap Technologies LtdRappaport Family Institute for Research in the Medical Sciences
Active IndicationsN/A
Inactive IndicationsMultiple Sclerosis

Other Information

ATC CodeN/A
Related LinksN/A